From: Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study
rATG n = 41
IL2-RA n = 147
P-value
Clinically-suspected acute rejection, % (n/n)
9.8 (4/41)
8.8 (13/147)
0.832
Graft lost because of rejection, n/na
0/4
4/13
–
Biopsy-proven acute rejection, n/N
1/9
6/12
0.01
Dn-DSA
2 (4.9)
8 (5.4)
0.44